昨今の HCV 治療
Saved in:
| Published in | 日大医学雑誌 Vol. 75; no. 6; pp. 251 - 253 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | Japanese |
| Published |
日本大学医学会
2016
|
| Online Access | Get full text |
| ISSN | 0029-0424 1884-0779 |
| DOI | 10.4264/numa.75.6_251 |
Cover
| Author | 楡井, 和重 森山, 光彦 |
|---|---|
| Author_xml | – sequence: 1 fullname: 楡井, 和重 organization: 日本大学医学部内科学系消化器肝臓内科学分野 – sequence: 1 fullname: 森山, 光彦 organization: 日本大学医学部内科学系消化器肝臓内科学分野 |
| BookMark | eNo9j7tKA0EYRn8kgmtMp31eYNa5_DuXRpBFEyGQRm2Hmd0Z3SVZZTcWllr6BPoGVha2eRxDfA0TFJvvKw4cOPvQa-6aAHDEaIpc4nHzMHepylJpecZ2IGFaI6FKmR4klHJDKHLcg0HXVZ5mGo1QiAkcrl_fV8uXr6eP4Ti_Hq4_l99vzwewG92sC4O_78PV-dllPiaT6egiP52QmintiDQs8hIjZcEjM5TT0gdtIvMRQxBS6kKEWGYGpdeovZPRsw30AjFKE0UfTn69dbdwN8Het9XctY_WtYuqmAW7bbIqs3I7m6x_UNy61tZO_ADaE01r |
| ContentType | Journal Article |
| Copyright | 2016 日本大学医学会 |
| Copyright_xml | – notice: 2016 日本大学医学会 |
| DOI | 10.4264/numa.75.6_251 |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1884-0779 |
| EndPage | 253 |
| ExternalDocumentID | article_numa_75_6_75_251_article_char_ja |
| GroupedDBID | 5GY ALMA_UNASSIGNED_HOLDINGS F5P JSF RJT |
| ID | FETCH-LOGICAL-j178a-691f2d4f01eb419020dbe89f1bf4ee3668c3efd5946b848ba6fb11bfb344f69f3 |
| ISSN | 0029-0424 |
| IngestDate | Wed Sep 03 06:22:43 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j178a-691f2d4f01eb419020dbe89f1bf4ee3668c3efd5946b848ba6fb11bfb344f69f3 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/numa/75/6/75_251/_article/-char/ja |
| PageCount | 3 |
| ParticipantIDs | jstage_primary_article_numa_75_6_75_251_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 2016 |
| PublicationDateYYYYMMDD | 2016-01-01 |
| PublicationDate_xml | – year: 2016 text: 2016 |
| PublicationDecade | 2010 |
| PublicationTitle | 日大医学雑誌 |
| PublicationTitleAlternate | 日大医誌 |
| PublicationYear | 2016 |
| Publisher | 日本大学医学会 |
| Publisher_xml | – name: 日本大学医学会 |
| References | 11) Naggie S, Cooper C, Saag M, et al. Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1. N Engl J Med 2015; 373: 705-713 6) Manns M, Marcellin P, Poordad F, et al. Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, doubleblind, placebo-controlled phase 3 trial. Lancet 2014; 384: 414-426. 8) Mizokami M, Yokosuka O, Takehara T, et al. Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial. Lancet Infect Dis 2015; 15: 645-653. 2) Chak E, Talal AH, Sherman KE, et al. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int 2011; 31: 1090-1101. 10) Coilly A, Roche B, Dumortier J, et al. Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience. J Hepatol 2014; 60: 78-86. 5) McHutchison JG, Gordon SC, Schiff ER, et al. Hepatitis Interventional Therapy Group. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339: 1485-1492. 1) Mohd Hanafiah K, Groeger J, Flaxman AD, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-1342. 3) Freeman AJ, Dore GJ, Law MG, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001; 34: 809-816. 4) Katayama K, Tanaka J, Komiya Y, et al. Significance of medical examination for HCV infection as a national project for prevention of hepatocellular carcinoma in Japan. Nihon Rinsho 2004; 62: 248-252. 9) Omata M, Nishiguchi S, Ueno Y, et al. Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial. J Viral Hepat 2014; 21: 762-768. 7) Kumada H, Suzuki Y, Ikeda K, et al. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. Hepatology 2014; 59 (6): 2083-2091. |
| References_xml | – reference: 10) Coilly A, Roche B, Dumortier J, et al. Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience. J Hepatol 2014; 60: 78-86. – reference: 4) Katayama K, Tanaka J, Komiya Y, et al. Significance of medical examination for HCV infection as a national project for prevention of hepatocellular carcinoma in Japan. Nihon Rinsho 2004; 62: 248-252. – reference: 8) Mizokami M, Yokosuka O, Takehara T, et al. Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial. Lancet Infect Dis 2015; 15: 645-653. – reference: 11) Naggie S, Cooper C, Saag M, et al. Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1. N Engl J Med 2015; 373: 705-713 – reference: 6) Manns M, Marcellin P, Poordad F, et al. Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, doubleblind, placebo-controlled phase 3 trial. Lancet 2014; 384: 414-426. – reference: 2) Chak E, Talal AH, Sherman KE, et al. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int 2011; 31: 1090-1101. – reference: 3) Freeman AJ, Dore GJ, Law MG, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001; 34: 809-816. – reference: 9) Omata M, Nishiguchi S, Ueno Y, et al. Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial. J Viral Hepat 2014; 21: 762-768. – reference: 1) Mohd Hanafiah K, Groeger J, Flaxman AD, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-1342. – reference: 7) Kumada H, Suzuki Y, Ikeda K, et al. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. Hepatology 2014; 59 (6): 2083-2091. – reference: 5) McHutchison JG, Gordon SC, Schiff ER, et al. Hepatitis Interventional Therapy Group. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339: 1485-1492. |
| SSID | ssib058493744 ssib004298531 ssib001535899 ssib007484389 ssj0000389138 ssib004001855 |
| Score | 2.0477545 |
| SourceID | jstage |
| SourceType | Publisher |
| StartPage | 251 |
| Title | 昨今の HCV 治療 |
| URI | https://www.jstage.jst.go.jp/article/numa/75/6/75_251/_article/-char/ja |
| Volume | 75 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 日大医学雑誌, 2016/12/01, Vol.75(6), pp.251-253 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1884-0779 dateEnd: 99991231 omitProxy: true ssIdentifier: ssib007484389 issn: 0029-0424 databaseCode: KQ8 dateStart: 20080101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELZWRUJcEFAQ_9oDc6qyJLHjn6M3DVqBioTUot6ieNc-rERBaPfCDY48AbwBJw7cUB8HVF6DmThps6KHUimyvLYnHu9Y48_xeIaxJyE1PuVqnqhUhUQggE0alwoEcqLB5Vb4RWtEs_dSzg7E88PicDT6ObBaWq_cZP7h3Hsll5EqlqFc6Zbsf0j29KVYgHmUL6YoYUwvJGOoJBgNVkMlYDoFbaHiiA3BVjuz8vUO1U9zqqkUGAMxAE-PRVtqBbaAqgArwCrK6LJtjyW7YCVUBswUTAYV9mOxtpcQUSOpzdq-LZiCpEWEJqeXIKFWoHc32nPkjJpMM3q69hof05ZSj8PPEPF-ZDtlBsxipgRbbnDdMfsv-8hbCcYOlXNO5zTxSvXER32stUhSFePN9Ao7hlrpJuaG9u181_ruFz9vjSAISD5n12-aiSomsj6l2nC73QmVArM0tSpqSQk2rfsKuhVXLxGaX8mVFKRcX7waHkDyYnigKij6YTHcuRoESmeqlVy68jPH_wgLETd2yKsFFe15su4Nluhvih5jaThPNwaDWGqJO4veKrEFSvs32PVuhzO2cQA32WjZ3GJX9zobjm22ffLl2-_jz78-fh_jHB2f_Dj-8_XTbXbwrNovZ0kXmyNZZko3iTRZyBcipJl3AkFlni6c1yZkLgjvuZR6zn1YFEZIp4V2jQwuw0rHhQjSBH6HbR29PfJ32TjTDYVMWzS5R2wuGs3nQYS5dArXC-fTe0zF8dTvogOW-qKyuX9pygfsGk3y-K3tIdtavV_7R4g-V-5xK-e_ZGpi8A |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%98%A8%E4%BB%8A%E3%81%AE+HCV+%E6%B2%BB%E7%99%82&rft.jtitle=%E6%97%A5%E5%A4%A7%E5%8C%BB%E5%AD%A6%E9%9B%91%E8%AA%8C&rft.au=%E6%A5%A1%E4%BA%95%2C+%E5%92%8C%E9%87%8D&rft.au=%E6%A3%AE%E5%B1%B1%2C+%E5%85%89%E5%BD%A6&rft.date=2016&rft.pub=%E6%97%A5%E6%9C%AC%E5%A4%A7%E5%AD%A6%E5%8C%BB%E5%AD%A6%E4%BC%9A&rft.issn=0029-0424&rft.eissn=1884-0779&rft.volume=75&rft.issue=6&rft.spage=251&rft.epage=253&rft_id=info:doi/10.4264%2Fnuma.75.6_251&rft.externalDocID=article_numa_75_6_75_251_article_char_ja |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0029-0424&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0029-0424&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0029-0424&client=summon |